跳至主要内容
临床试验/NL-OMON32335
NL-OMON32335已完成3 期

Prevention of progression of duodenal adenomas to cancer in patients with familial adenomatous polyposis. - Duodenal adenomas and cancer in patients with FAP.

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Patients with FAP with duodenal adenomas of Spigelman stage II and III, with an indication for duodenoscopy
  • -Patients with dyspeptic complaints with an indication for duodenoscopy, but without intestinal abnormalities.
  • - Age between18-70 years

排除标准

  • - Patients with a history of a cardiovascular accident, gallstones, gastric or duodenal ulcers, a prior allergic reaction on NSAIDs or UDCA or disturbed renal (creatinine clearance < 50 ml/min.) or liver function (albumin < 25 g/l or Child-Pugh-score >= 10) will be excluded. No NSAIDs or UDCA may have been used during enrolment.
  • - Cardiac patients NYHA class II-IV.
  • - Age below 18 or above 70 years or incapable to sign informed consent

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验